The International Journal of Tuberculosis and Lung Disease

Launch of the IJTLD Clinical Standards for Lung Health
pp. 781-783(3)
Authors: Otto-Knapp, R.; Häcker, B.; Bauer, T. T.

Person-centred care in TB
pp. 784-787(4)
Authors: Horter, S.; Daftary, A.; Keam, T.; Bernays, S.; Bhanushali, K.; Chavan, D.; Denholm, J.; Furin, J.; Jaramillo, E.; Khan, A.; Lin, Y. D.; Lobo, R.; Loveday, M.; Majumdar, S. S.; Mistry, N.; Patel, H.; Rane, S.; Swaminathan, A.; Triasih, R.; Venkatesan, N.; Viney, K.; du Cros, P.

Inhaled remdesivir treatment for COVID-19
pp. 788-790(3)
Authors: Yang, C.; Zhao, H.

Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB
pp. 791-794(4)
Authors: Köser, C. U.; Robledo, J.; Shubladze, N.; Schön, T.; Dolinger, D. L.; Salfinger, M.

A bold new future for the IJTLD
pp. 795-796(2)
Authors: Migliori, G. B.; Blackbourn, H. D.

Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
pp. 797-813(17)
Authors: Migliori, G. B.; Marx, F. M.; Ambrosino, N.; Zampogna, E.; Schaaf, H. S.; van der Zalm, M. M.; Allwood, B.; Byrne, A. L.; Mortimer, K.; Wallis, R. S.; Fox, G. J.; Leung, C. C.; Chakaya, J. M.; Seaworth, B.; Rachow, A.; Marais, B. J.; Furin, J.; Akkerman, O. W.; Al Yaquobi, F.; Amaral, A. F. S.; Borisov, S.; Caminero, J. A.; Carvalho, A. C. C.; Chesov, D.; Codecasa, L. R.; Teixeira, R. C.; Dalcolmo, M. P.; Datta, S.; Dinh-Xuan, A-T.; Duarte, R.; Evans, C. A.; García-García, J-M.; Günther, G.; Hoddinott, G.; Huddart, S.; Ivanova, O.; Laniado-Laborín, R.; Manga, S.; Manika, K.; Mariandyshev, A.; Mello, F. C. Q.; Mpagama, S. G.; Muñoz-Torrico, M.; Nahid, P.; Ong, C. W. M.; Palmero, D. J.; Piubello, A.; Pontali, E.; Silva, D. R.; Singla, R.; Spanevello, A.; Tiberi, S.; Udwadia, Z. F.; Vitacca, M.; Centis, R.; D´Ambrosio, L.; Sotgiu, G.; Lange, C.; Visca, D.

Challenges in recruiting children to a multidrug-resistant TB prevention trial
pp. 814-822(9)
Authors: Purchase, S.; Batist, E.; Mmile, N.; Nkosi, S.; Workman, J.; Martinson, N.; Fairlie, L.; Schaaf, H. S.; Choo, L.; McGowan, C.; Crook, A. M.; Seddon, J. A.; Hesseling, A. C.

TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up
pp. 823-831(9)
Authors: Oxlade, O.; den Boon, S.; Menzies, D.; Falzon, D.; Lane, M. Y.; Kanchar, A.; Zignol, M.; Matteelli, A.

Rifampicin-resistant TB: discordance between Xpert^® MTB/RIF and MTBDRplus results
pp. 832-838(7)
Authors: Black, M.; Da Silva, P.; Scott, L.

Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial
pp. 839-845(7)
Authors: Ejo, M.; Van Deun, A.; Nunn, A.; Meredith, S.; Ahmed, S.; Dalai, D.; Tumenbayar, O.; Tsogt, B.; Dat, P. T.; Ha, D. T. M.; Hang, P. T.; Kokebu, D.; Teferi, M.; Mebrahtu, T.; Ngubane, N.; Moodliar, R.; Duckworth, L.; Conradie, F.; Enduwamahoro, E.; Keysers, J.; De Rijk, P.; Mulders, W.; Diro, E.; Rigouts, L.; de Jong, B. C.; Torrea;, G.; on behalf of the STREAM collaborators

The burden and determinants of post-TB lung disease
pp. 846-853(8)
Authors: Mpagama, S. G.; Msaji, K. S.; Kaswaga, O.; Zurba, L. J.; Mbelele, P. M.; Allwood, B. W.; Ngungwa, B-S.; Kisonga, R. M.; Lesosky, M.; Rylance, J.; Mortimer, K.; on behalf of the lung health in Africa across the life course collaboration

Impact of COVID-19 on TB epidemiology in South Korea
pp. 854-860(7)
Authors: Choi, H.; Ko, Y.; Lee, C. Y.; Chung, S. J.; Kim, H. I.; Kim, J-H.; Park, S.; Hwang, Y. I.; Jang, S. H.; Jung, K-S.; Kim, Y. K.; Park, J. Y.

Phenotypic vs. genotypic resistance to fluoroquinolones in rifampicin-resistant TB
pp. 861-863(3)
Authors: Tahseen, S.; Khanzada, F. M.; Hussain, A.; Akhtar, N.

Urine LAM diagnostics can close the deadly testing gap for TB
pp. 864-865(2)
Authors: Deborggraeve, S.; Menghaney, L.; Lynch, S.; McKenna, L.; Branigan, D.

Clinical experience of TB in patients treated with anti-TNF-α
pp. 866-868(3)
Authors: Arenas-Miras, M.; Sánchez-Martínez, F.; Jové-Caballé, N.; Villar-García, J.; López-Montesinos, I.; Grau, S.; Carballo, N.; Knobel-Freud, H.; Horcajada, J.P.

Automated detection and reduction of stigma in online discussions about TB
pp. 869-870(2)
Authors: Hassan, L.; Ali, S. M.; Iqbal, W.; Baig, S.; Viney, K.; Hadi, H.

Digital technologies and loss to follow-up for TB patients
pp. 871-872(2)
Authors: Sekandi, J. N.; Tucker, E. G.; Zalwango, S.; Buregyeya, E.

Impact of COVID-19 on hospitalisations for asthma
pp. 873-875(3)
Authors: Zhang, L.; Castro, Y. M.; Camargos, P.

Proposal for an alternative classification for difficult-to-treat TB
pp. 876-877(2)
Authors: Klopper, M.; Warren, R. M.; van Rie, A.